S&P 500   3,247.79 (+0.34%)
DOW   26,829.47 (+0.25%)
QQQ   267.10 (+1.11%)
AAPL   109.05 (+1.80%)
MSFT   204.28 (+1.84%)
FB   250.69 (+0.67%)
GOOGL   1,431.99 (+1.60%)
AMZN   3,041.16 (+1.38%)
NVDA   500.65 (+3.24%)
TSLA   394.27 (+3.66%)
BABA   270.30 (-0.97%)
CGC   14.35 (-1.71%)
GE   6.11 (+0.00%)
MU   49.97 (+0.24%)
AMD   76.42 (+2.26%)
T   28.07 (+0.72%)
F   6.71 (+1.05%)
ACB   5.16 (-0.19%)
GILD   62.02 (-1.70%)
NFLX   475.46 (+1.03%)
DIS   122.94 (-0.28%)
BAC   23.52 (+1.12%)
BA   147.15 (-2.67%)
S&P 500   3,247.79 (+0.34%)
DOW   26,829.47 (+0.25%)
QQQ   267.10 (+1.11%)
AAPL   109.05 (+1.80%)
MSFT   204.28 (+1.84%)
FB   250.69 (+0.67%)
GOOGL   1,431.99 (+1.60%)
AMZN   3,041.16 (+1.38%)
NVDA   500.65 (+3.24%)
TSLA   394.27 (+3.66%)
BABA   270.30 (-0.97%)
CGC   14.35 (-1.71%)
GE   6.11 (+0.00%)
MU   49.97 (+0.24%)
AMD   76.42 (+2.26%)
T   28.07 (+0.72%)
F   6.71 (+1.05%)
ACB   5.16 (-0.19%)
GILD   62.02 (-1.70%)
NFLX   475.46 (+1.03%)
DIS   122.94 (-0.28%)
BAC   23.52 (+1.12%)
BA   147.15 (-2.67%)
S&P 500   3,247.79 (+0.34%)
DOW   26,829.47 (+0.25%)
QQQ   267.10 (+1.11%)
AAPL   109.05 (+1.80%)
MSFT   204.28 (+1.84%)
FB   250.69 (+0.67%)
GOOGL   1,431.99 (+1.60%)
AMZN   3,041.16 (+1.38%)
NVDA   500.65 (+3.24%)
TSLA   394.27 (+3.66%)
BABA   270.30 (-0.97%)
CGC   14.35 (-1.71%)
GE   6.11 (+0.00%)
MU   49.97 (+0.24%)
AMD   76.42 (+2.26%)
T   28.07 (+0.72%)
F   6.71 (+1.05%)
ACB   5.16 (-0.19%)
GILD   62.02 (-1.70%)
NFLX   475.46 (+1.03%)
DIS   122.94 (-0.28%)
BAC   23.52 (+1.12%)
BA   147.15 (-2.67%)
S&P 500   3,247.79 (+0.34%)
DOW   26,829.47 (+0.25%)
QQQ   267.10 (+1.11%)
AAPL   109.05 (+1.80%)
MSFT   204.28 (+1.84%)
FB   250.69 (+0.67%)
GOOGL   1,431.99 (+1.60%)
AMZN   3,041.16 (+1.38%)
NVDA   500.65 (+3.24%)
TSLA   394.27 (+3.66%)
BABA   270.30 (-0.97%)
CGC   14.35 (-1.71%)
GE   6.11 (+0.00%)
MU   49.97 (+0.24%)
AMD   76.42 (+2.26%)
T   28.07 (+0.72%)
F   6.71 (+1.05%)
ACB   5.16 (-0.19%)
GILD   62.02 (-1.70%)
NFLX   475.46 (+1.03%)
DIS   122.94 (-0.28%)
BAC   23.52 (+1.12%)
BA   147.15 (-2.67%)
Log in
NYSE:OSH

Oak Street Health Stock Forecast, Price & News

$44.84
+2.64 (+6.26 %)
(As of 09/24/2020 02:44 PM ET)
Add
Compare
Today's Range
$43.12
Now: $44.84
$45.28
50-Day Range N/A
52-Week Range
$37.11
Now: $44.84
$53.58
Volume5,504 shs
Average Volume456,023 shs
Market Capitalization$10.70 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Oak Street Health, Inc., through its subsidiaries, engages in designing and building the Oak Street platform to address the unmet needs of the chronically ill Medicare population in the United States. It operates primary care centers serving Medicare beneficiaries. The company contracts with health plans to generate medical costs savings and realize a return on its investment in primary care. As of March 31, 2020, it operated 54 centers in Illinois, Indiana, Michigan, Ohio, Pennsylvania, Rhode Island, North Carolina, and Tennessee. Oak Street Health, Inc. was founded in 2012 and is headquartered in Chicago, Illinois.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.29 out of 5 stars


Industry, Sector and Symbol

Industry Health services
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone312-733-9730

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees2,300
Market Cap$10.70 billion
Next Earnings Date12/16/2020 (Estimated)
OptionableNot Optionable
$44.84
+2.64 (+6.26 %)
(As of 09/24/2020 02:44 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive OSH News and Ratings via Email

Sign-up to receive the latest news and ratings for OSH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Oak Street Health (NYSE:OSH) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Oak Street Health?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Oak Street Health in the last year. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Oak Street Health
.

When is Oak Street Health's next earnings date?

Oak Street Health is scheduled to release its next quarterly earnings announcement on Wednesday, December 16th 2020.
View our earnings forecast for Oak Street Health
.

How were Oak Street Health's earnings last quarter?

Oak Street Health (NYSE:OSH) announced its earnings results on Wednesday, September, 16th. The company reported ($72.53) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.12) by $72.41.
View Oak Street Health's earnings history
.

What price target have analysts set for OSH?

8 brokerages have issued 12-month price objectives for Oak Street Health's shares. Their forecasts range from $50.00 to $66.00. On average, they anticipate Oak Street Health's share price to reach $55.43 in the next twelve months. This suggests a possible upside of 23.6% from the stock's current price.
View analysts' price targets for Oak Street Health
.

Who are some of Oak Street Health's key competitors?

What other stocks do shareholders of Oak Street Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oak Street Health investors own include Adobe (ADBE), Tesla (TSLA), Alibaba Group (BABA), NVIDIA (NVDA), Zoom Video Communications (ZM), Advanced Micro Devices (AMD), Boeing (BA), Berkshire Hathaway (BRK.A), salesforce.com (CRM) and Walt Disney (DIS).

Who are Oak Street Health's key executives?

Oak Street Health's management team includes the following people:
  • Mr. Michael T. Pykosz, Chairman & CEO (Age 38, Pay $1.12M)
  • Mr. Geoffrey M. Price, COO & Director (Age 38, Pay $905.24k)
  • Mr. Griffin Myers, Chief Medical Officer & Director (Age 39, Pay $661.28k)
  • Mr. Brian Clem, Pres (Age 38)
  • Mr. Timothy M. Cook, Chief Financial Officer

When did Oak Street Health IPO?

(OSH) raised $250 million in an initial public offering on Thursday, August 6th 2020. The company issued 15,600,000 shares at $15.00-$17.00 per share. J.P. Morgan, Goldman Sachs and Morgan Stanley acted as the underwriters for the IPO and William Blair, Piper Sandler, Baird and SunTrust Robinson Humphrey were co-managers.

What is Oak Street Health's stock symbol?

Oak Street Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "OSH."

When did Oak Street Health's quiet period expire?

Oak Street Health's quiet period expired on Tuesday, September 15th. Oak Street Health had issued 15,625,000 shares in its initial public offering on August 6th. The total size of the offering was $328,125,000 based on an initial share price of $21.00. During Oak Street Health's quiet period, insiders and underwriters involved in the IPO were restricted from issuing any research reports or earnings estimates for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Oak Street Health?

Shares of OSH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Oak Street Health's stock price today?

One share of OSH stock can currently be purchased for approximately $44.84.

How big of a company is Oak Street Health?

Oak Street Health has a market capitalization of $10.70 billion. Oak Street Health employs 2,300 workers across the globe.

What is Oak Street Health's official website?

The official website for Oak Street Health is www.oakstreethealth.com.

How can I contact Oak Street Health?

Oak Street Health's mailing address is 30 W. MONROE ST. STE. 1200, CHICAGO IL, 60603. The company can be reached via phone at 312-733-9730 or via email at [email protected]

This page was last updated on 9/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.